Reports often mention reduced muscle tightness, less joint discomfort after high-volume days, and an overall quicker bounce-back between sessions
In todays discussion, we dive into the next frontier of peptide therapeutics, and specifically - oral delivery
This enhanced metabolic effectiveness, with a convenient oral route of administration and known CV protection, leads oral semaglutide to be a highly effective non-injectable option for patients who need high levels of cardiometabolic risk management
Muscle loss can also slow your burn
Meanwhile, the lower maximum dose creates a bigger need for patients to engage whole-heartedly in supportive lifestyle changes throughout the programme, which should help with losing weight and with keeping it off. Abstact contact - Dr Henrik Gudbergsen, Chief Medical Officer at Embla ApS, Denmark